A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)

Clinical trial NCT07463183 · RECRUITING

Trial details

NCT number: NCT07463183
Sponsor: Merck Sharp & Dohme LLC
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Colitis Ulcerative Ulcerative Colitis

Start date: 2026-03-24
Primary completion: 2027-10-28
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.